The 20 Best Febrile Neutropenia Doctors near Randolph, NJ

Danya Wenzler is an Infectious Disease provider in Randolph, New Jersey. Dr. Wenzler is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Sepsis, Pneumonia, Lymphangitis, and Streptococcal Group B Infection. Dr. Wenzler is currently accepting new patients.

Stephen Williams is an Infectious Disease provider in Randolph, New Jersey. Dr. Williams is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Sepsis, Cellulitis, Lymphangitis, and Infective Endocarditis. Dr. Williams is currently accepting new patients.

Joseph Kim is an Infectious Disease provider in Randolph, New Jersey. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Sepsis, COVID-19, Bacterial Gastroenteritis, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Prostatectomy. Dr. Kim is currently accepting new patients.

Theodore Markou is an Infectious Disease provider in Randolph, New Jersey. Dr. Markou is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Sepsis, Pneumonia, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Markou is currently accepting new patients.

Edward Mcmanus is an Infectious Disease provider in Randolph, New Jersey. Dr. Mcmanus has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Lyme Disease, Lymphangitis, Sepsis, and Osteomyelitis. Dr. Mcmanus is currently accepting new patients.

Melanie Torres is an Infectious Disease provider in Randolph, New Jersey. Dr. Torres is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Sepsis, Hospital-Acquired Pneumonia, Pneumonia, and Lymphangitis. Dr. Torres is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Najah Doka is an Infectious Disease provider in Cedar Knolls, New Jersey. Dr. Doka is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Sepsis, Pneumonia, COVID-19, and Bacterial Gastroenteritis. Dr. Doka is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Beth Leiter is a Nurse Practitioner in Randolph, New Jersey. Ms. Leiter is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Bacterial Gastroenteritis, Pneumonia, Strep Throat, and Hospital-Acquired Pneumonia.

Christopher Tully is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Tully is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Lung Cancer. Dr. Tully is currently accepting new patients.

Naveed Jan is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Jan is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Vitamin B12 Deficiency. Dr. Jan is currently accepting new patients.

Fazila Aslam is an Infectious Disease provider in Cedar Knolls, New Jersey. Dr. Aslam is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Sepsis, Lymphangitis, Cellulitis, and Pneumonia. Dr. Aslam is currently accepting new patients.

Damanpreet Ubhi is an Infectious Disease provider in Cedar Knolls, New Jersey. Dr. Ubhi is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Sepsis, Lymphangitis, Cellulitis, and Pneumonia. Dr. Ubhi is currently accepting new patients.

Fazal Bari is a Hematologist and an Oncologist in Mountain Lakes, New Jersey. Dr. Bari is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Colorectal Cancer. Dr. Bari is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Advanced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Karim R. Saab, MD, is a fellowship-trained hematology oncology specialist with Atlantic Medical Group Hematology Oncology. Triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine, Dr. Saab has years of teaching experience and clinical knowledge.After graduating with distinction from the School of Medicine at the American University of Beirut, Lebanon, Dr. Saab served as a research scholar and postdoctoral research fellow in the Department of Surgery at St. Jude Children’s Research Hospital, Memphis, TN, followed by two years as a postdoctoral research fellow at Harvard Medical School, Brigham and Women’s Hospital, and Children’s Hospital Boston, Transplantation Research Center, Boston, MA. He performed his residency in internal medicine at the University of Colorado, Aurora, CO, where he was awarded the internal medicine resident research publication award, followed by a fellowship in hematology and medical oncology at Weill Cornell Medical College / New York-Presbyterian Hospital, New York, NY.Before joining Atlantic Medical Group Hematology Oncology, Dr. Saab worked at Hennepin Healthcare in Minneapolis, MN, where he also served as assistant professor of medicine at the University of Minnesota. Dr. Saab has been involved in teaching hematology and medical oncology fellows, residents, medical and physician assistant students, as well as teaching medical students at Weill Cornell Medical College. Actively involved in research, Dr. Saab has studied biomarkers for diagnosis, disease progression and response to therapy; cancer stem cell biology; and antiangiogenic therapy for solid tumors. He has been published in many peer-reviewed journals and presented at national conferences.Dr. Saab is an active member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, and American Physician Scientists Association. He is fluent in French and Arabic. Dr. Saab is a participating provider of the Atlantic Accountable Care Organization. Dr. Saab is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Large-Cell Lung Carcinoma.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Nazia Khan, MD is a hematologist and oncologist with Atlantic Medical Group, overseeing the Atlantic Medical Group Bridgewater Pavilion Infusion Center. She is board certified in internal medicine, medical oncology and hematology, and fellowship-trained in hematology and oncology. Dr. Khan treats a wide range of cancers and blood disorders and helps patients cope with the challenges these illnesses may present to multiple systems in the body. Using an evidence-based approach to patient care, she employs state-of-the-art treatment protocols in collaboration with other specialists to help patients manage their illness and achieve a better quality of life. In her role as director of the infusion center, she oversees outpatient treatments including intravenous chemotherapy, immunotherapy, and biotherapy, providing patients with access to the leading-edge cancer treatments in a caring and safe environment. Dr. Khan participates in ongoing clinical trials and is dedicated to teaching medical students and residents and fellows the principles of hematology/oncology. She has served as an adjunct clinical assistant professor at Touro College of Osteopathic Medicine, NY, and is an active faculty member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Khan is originally from India where she attended the Maulana Azad Medical College in New Delhi. She came to the United States to pursue a residency at Seton Hall University School of Health and Sciences, Trinitas Regional Medical Center, NJ, and a fellowship at New York Medical College/St. Joseph’s University Medical Center, NJ. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Lymphofollicular Hyperplasia, Malignant Peripheral Nerve Sheath Tumor, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.